Dyadic International, Inc.
NASDAQ:DYAIBiotechnology
+$0.26 today
- Market cap
- $53.56M
- Beta
- 1.15
- P/E (TTM)
- -6.9
- EPS (TTM)
- -$0.20
Volume 0.71M
Average 0.31M
DYAI Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Dyadic International, Inc.NASDAQ: DYAI
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue growth accelerates
Q1 FY2026 revenue of $1.11M rose 506.7% year over year, ahead of the -11.0% change in trailing-twelve-month revenue. Sequentially, it rose 371.3% from the prior quarter. Over 3 fiscal years it compounded at -25.1% a year.
Context
- Revenue increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 2 analysts of $6.82M (+453.3%) for the fiscal year ending Dec 2026, a step up from the -64.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $1.11M+371.3% QoQ
- Last fiscal yearDec 2025
- $1.23M-64.7% YoY
- LTMMar 2026
- $2.97M-11.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +506.7% | +121.3% | -385.5 pp |
| 1 year | -64.7% | +453.3% | +518.1 pp |
| 3-year CAGR | -25.1% | +107.4% | +132.5 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 1.23M USD
- Year-over-year change
- -64.7%
- 4-year CAGR
- -15.4%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.23M | -64.7% |
| FY2024 | 2024-12-31 | 3.5M | +20.6% |
| FY2023 | 2023-12-31 | 2.9M | -1.1% |
| FY2022 | 2022-12-31 | 2.93M | +21.9% |
| FY2021 | 2021-12-31 | 2.4M | — |
Revenue vs competitors
How DYAI compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of -11.0% is the 3rd highest of 5, against a peer median of -7.9%.
- Over three fiscal years its annual growth of -25.1% compares with a peer median of +7.9%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Dec 2025 | $26.55M USD | -51.0% | +13.9% | |
| FY2025 | A$5.44M AUD | +35.3% | +2.0% | |
| LTM Mar 2026 | $2.97M USD | -11.0% | -25.1% | |
| LTM Mar 2026 | $1.49M USD | +520.4% | — | |
| LTM Mar 2026 | $0 USD | — | — | |
| LTM Mar 2026 | $0 USD | — | — | |
| LTM Mar 2026 | $0 USD | -100.0% | — | |
| LTM Mar 2026 | $0 USD | — | — | |
| Peer median (excluding DYAI) | — | -7.9% | +7.9% | |
Competitors are the stored peer set for DYAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.4M | 2.93M | 2.9M | 3.5M | 1.23M |
| Cost of Revenue | 1.94M | 2.12M | 1.98M | 1.19M | 2.32M |
| Gross Profit | 459.39K | 807.11K | 922.96K | 2.3M | (1.09M) |
| Gross Margin | 19.1% | 27.5% | 31.8% | 65.8% | -88.3% |
| Research & Development | 8.39M | 4.5M | 3.3M | 2.04M | 2.15M |
| Selling, General & Admin | 6.7M | 6.42M | 5.82M | 6.13M | 5.76M |
| Operating Expenses | 15.19M | 10.97M | 9.15M | 8.2M | 6.06M |
| Depreciation & Amortization | 3.49M | 0 | 38.42K | 0 | 0 |
| EBITDA | (11.14M) | (10.12M) | (8.15M) | (5.38M) | (6.91M) |
| EBITDA Margin | -463.4% | -345.2% | -281.3% | -154.0% | -560.6% |
| Operating Income | (14.73M) | (10.17M) | (8.23M) | (5.9M) | (7.15M) |
| Operating Margin | -612.7% | -346.9% | -283.9% | -168.8% | -579.9% |
| Interest Income | 51.7K | 180.42K | 416.69K | 456.99K | 284.09K |
| Interest Expense | 0 | 0 | 0 | 427.97K | 455.9K |
| Other Income / Expenses | 1.66M | 430.42K | 1.43M | 91.66K | (218.71K) |
| Income Before Tax | (13.07M) | (9.74M) | (6.8M) | (5.81M) | (7.36M) |
| Pre-Tax Margin | -543.7% | -332.2% | -234.4% | -166.2% | -597.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (13.07M) | (9.74M) | (6.8M) | (5.81M) | (7.36M) |
| Net Margin | -543.7% | -332.2% | -234.4% | -166.2% | -597.6% |
| EPS (Basic) | (0.47) | (0.34) | (0.24) | (0.20) | (0.23) |
| EPS (Diluted) | (0.47) | (0.34) | (0.24) | (0.20) | (0.23) |
| Weighted Avg Shares | 27.84M | 28.36M | 28.8M | 29.32M | 32.62M |
| Weighted Avg Shares (Diluted) | 27.84M | 28.36M | 28.8M | 29.32M | 32.62M |
Dyadic International, Inc.
NASDAQ:DYAI
Intrinsic Alpha fair value
Locked
Current Price
$1.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.